MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1	https://doi.org/10.1007/s13277-015-3120-0	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1	https://doi.org/10.1016/j.bbrc.2018.06.121	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis	https://doi.org/10.1016/j.bbrc.2018.07.137	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect	https://doi.org/10.1016/j.bbrc.2018.08.035	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-217 targeting Wnt5a in osteosarcoma functions as a potential tumor suppressor	https://doi.org/10.1016/j.biopha.2015.04.012	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells	https://doi.org/10.1016/j.biopha.2016.09.108	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
RSF1 functions as an oncogene in osteosarcoma and is regulated by XIST/miR-193a-3p axis	https://doi.org/10.1016/j.biopha.2017.08.068	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9	https://doi.org/10.1016/j.biopha.2018.06.124	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis	https://doi.org/10.1016/j.biopha.2019.108798	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-?1	https://doi.org/10.1016/j.gene.2016.03.021	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-1301 inhibits migration and invasion of osteosarcoma cells by targeting BCL9	https://doi.org/10.1016/j.gene.2018.08.078	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Role of microRNA-503 in the suppression of osteosarcoma cell proliferation and migration via modulation of fibroblast growth factor 2	https://doi.org/10.3892/mmr.2015.4399	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Expression of miR-664 and miR-184 on proliferation, apoptosis and migration of osteosarcoma cells	https://doi.org/10.3892/ol.2018.9739	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4	https://doi.org/10.1016/j.jbo.2016.02.002	2016	Cell line 0 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting ?B-crystallin	https://doi.org/10.1016/j.ymthe.2017.05.018	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-218 expression in osteosarcoma tissues and its effect on cell growth in osteosarcoma cells	https://doi.org/10.1016/S1995-7645(14)60176-0	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma	https://doi.org/10.1038/srep41456	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma	https://doi.org/10.1074/jbc.M112.445890	2013	Cell line 1 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-145-3p suppresses proliferation and promotes apotosis and autophagy of osteosarcoma cell by targeting HDAC4	https://doi.org/10.1080/21691401.2018.1464459	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP	https://doi.org/10.1080/21691401.2019.1601099	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications